reportingrisk.com← the monitorSEC reporting failures, scored and checked against what happened next

Or browse all companies A–Z.

Vaccinex, Inc.

VCNX · OTC

No reporting failures in the last 12 months

It filed on time and stood behind its numbers. Of companies scoring zero, 4.0% were delisted, went bankrupt, restated or stopped filing within the following year.

$6Mstalepublic float
2025-04-01most recent failure

Score over time

012202220232024202520262024-07-01 · score 12024-04-02 filed late (10-K)2024-10-01 · score 12024-04-02 filed late (10-K)2025-01-01 · score 12024-04-02 filed late (10-K)2025-04-01 · score 12024-04-02 filed late (10-K)2025-07-01 · score 12025-04-01 filed late (10-K) · accounts not ready2025-10-01 · score 12025-04-01 filed late (10-K) · accounts not ready2026-01-01 · score 12025-04-01 filed late (10-K) · accounts not ready2026-04-01 · score 12025-04-01 filed late (10-K) · accounts not ready

Hover or tap a dot to see the filings behind that score.

Why they said they were late

Vaccinex, Inc. (the “Company”) was unable to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the “Form 10-K”) within the prescribed time period without unreasonable effort or expense due to delays it has experienced in completing its financial statements for the year ended December 31, 2024. The Company expects to file the Form 10-K as soon as possible, but no later than the fifteenth calendar day extension period provided under Rule 12b-25

NT 10-K, filed 2025-04-01 · accounts not ready

What it filed

2025-04-01filed late (10-K)accounts not ready SEC →

Vaccinex, Inc. (the “Company”) was unable to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the “Form 10-K”) within the prescribed time period without unreasonable effort or expense due to delays it has experienced in completing its financial statements for the year ended December 31, 2024. The Company expects to file the Form 10-K as soon as possible, but no later than the fifteenth calendar day extension period provided under Rule 12b-25

2024-04-02filed late (10-K) SEC →

Vaccinex Inc. (the “Company”) was unable to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “Form 10-K”) within the prescribed time period without unreasonable effort or expense due to technical difficulties that arose in the process of submitting the Form 10-K for filing. The Company expects to file the Form 10-K as soon as possible, but no later than the fifteenth calendar day extension period provided under Rule 12b-25

About this score

reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.

Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.

See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.

Every item above is a filing this company made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not investment advice

reportingrisk.com← back to the monitorAll companies A-Z · RSS · found an error? hello@reportingrisk.com